Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis

NB Cyrille, J Goldsmith, J Alvarez, MS Maurer - The American journal of …, 2014 - Elsevier
Low voltage is classically reported as an electrocardiographic (ECG) finding in cardiac
amyloidosis (CA). We evaluated electrocardiograms to determine the prevalence of low …

Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis

MB Musumeci, F Cappelli, D Russo, G Tini… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to assess the diagnostic accuracy of bone scintigraphy
in a large multicenter cohort of patients with cardiac amyloidotic involvement and Phe64Leu …

Utility and limitations of 3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in systemic amyloidosis

DF Hutt, AM Quigley, J Page, ML Hall… - European Heart …, 2014 - academic.oup.com
Abstract Aims Technetium-99m-labelled 3, 3-diphosphono-1, 2-propanodicarboxylic acid
(99mTc-DPD) is a sensitive method for imaging cardiac transthyretin (ATTR) amyloid. We …

Cardiac amyloidosis: the great pretender

C Rapezzi, M Lorenzini, S Longhi, A Milandri… - Heart failure …, 2015 - Springer
Cardiac amyloidosis (CA) is often misdiagnosed because of both physician-related and
disease-related reasons including: fragmented knowledge among different specialties and …

Canadian Cardiovascular Society/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis

NM Fine, MK Davis, K Anderson, DH Delgado… - Canadian Journal of …, 2020 - Elsevier
Cardiac amyloidosis is an under-recognized and potentially fatal cause of heart failure and
other cardiovascular manifestations. It is caused by deposition of misfolded precursor …

A practical approach to the diagnosis of systemic amyloidoses

C Fernández de Larrea, L Verga… - Blood, The Journal …, 2015 - ashpublications.org
Accurate diagnosis of systemic amyloidosis is necessary both for assessing the prognosis
and for delineating the appropriate treatment. It is based on histologic evidence of amyloid …

Screening for cardiac amyloidosis 5 to 15 years after surgery for bilateral carpal tunnel syndrome

O Westin, EL Fosbøl, MS Maurer, BP Leicht… - Journal of the American …, 2022 - jacc.org
Background Bilateral carpal tunnel syndrome (CTS) is a common extracardiac manifestation
of amyloidosis and usually predates overt cardiac amyloidosis (CA) by several years …

Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome

C Nitsche, S Aschauer… - European Journal of …, 2020 - Wiley Online Library
Aims Concomitant cardiac amyloidosis (CA) in severe aortic stenosis (AS) is difficult to
recognize, since both conditions are associated with concentric left ventricular thickening …

[HTML][HTML] Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers

P Kyriakou, D Mouselimis, A Tsarouchas… - BMC cardiovascular …, 2018 - Springer
Abstract Background Cardiac Amyloidosis (CA) pertains to the cardiac involvement of a
group of diseases, in which misfolded proteins deposit in tissues and cause progressive …

AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review

AD Wechalekar, M Fontana, CC Quarta, M Liedtke - Cardio Oncology, 2022 - jacc.org
Amyloid light chain (AL) amyloidosis is a rare, debilitating, often fatal disease. Symptoms of
cardiomyopathy are common presenting features, and patients often are referred to …